US Patent 10039800 | Patents | Expiry | Expiration | Dates

SILVERGATE PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LISINOPRIL

Supporting Information : Click here to upload a PDF

US Patent Number

10039800

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-11-06

Patent Use Code

U-185

Delist Requested

Application Number

208401

Patent Use Description

METHOD OF TREATING HYPERTENSION

Product Number

1

SILVERGATE PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LISINOPRIL

Supporting Information : Click here to upload a PDF

US Patent Number

10039800

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-11-06

Patent Use Code

U-3

Delist Requested

Application Number

208401

Patent Use Description

TREATMENT OF HYPERTENSION

Product Number

1

SILVERGATE PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LISINOPRIL

Supporting Information : Click here to upload a PDF

US Patent Number

10039800

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-11-06

Patent Use Code

U-1723

Delist Requested

Application Number

208401

Patent Use Description

TREATMENT OF HEART FAILURE

Product Number

1

SILVERGATE PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LISINOPRIL

Supporting Information : Click here to upload a PDF

US Patent Number

10039800

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-11-06

Patent Use Code

U-71

Delist Requested

Application Number

208401

Patent Use Description

METHOD OF TREATMENT OF HEART FAILURE

Product Number

1

SILVERGATE PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LISINOPRIL

Supporting Information : Click here to upload a PDF

US Patent Number

10039800

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-11-06

Patent Use Code

U-1991

Delist Requested

Application Number

208401

Patent Use Description

Product Number

1

SILVERGATE PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LISINOPRIL

Supporting Information : Click here to upload a PDF

US Patent Number

10039800

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-11-06

Patent Use Code

U-1864

Delist Requested

Application Number

208401

Patent Use Description

TREATMENT OF MYOCARDIAL INFARCTION

Product Number

1

SILVERGATE PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LISINOPRIL

Supporting Information : Click here to upload a PDF

US Patent Number

10039800

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-11-06

Patent Use Code

U-8

Delist Requested

Application Number

208401

Patent Use Description

ACUTE MYOCARDIAL INFARCTION

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10039800

2035-11-06

U-185

METHOD OF TREATING HYPERTENSION

1

2035-11-06

U-3

TREATMENT OF HYPERTENSION

1

2035-11-06

U-1723

TREATMENT OF HEART FAILURE

1

2035-11-06

U-71

METHOD OF TREATMENT OF HEART FAILURE

1

2035-11-06

U-1991

1

2035-11-06

U-1864

TREATMENT OF MYOCARDIAL INFARCTION

1

2035-11-06

U-8

ACUTE MYOCARDIAL INFARCTION

1